коцка
Curiouser and curiouser!
21ви век сме, ноу џендер сум
Коронавирус (COVID-19) - Општа дискусија
- Креатор на темата A__
- Време на започнување
TOT
sorcerer
Нозете со влакна на следен натпревар сликај ги.21ви век сме, ноу џендер сум
коцка
Curiouser and curiouser!
назад на темата, ако сакаш нозе со влакна да фотнам, пријави се на фото натпреварите, победи и дади тема
- Член од
- 30 август 2021
- Мислења
- 1.243
- Поени од реакции
- 2.628
А за победа на фотонатпревар може ли наградата да биде да ги отстраниш Рон и овој другиот од темава?назад на темата, ако сакаш нозе со влакна да фотнам, пријави се на фото натпреварите, победи и дади тема
- Член од
- 13 јули 2006
- Мислења
- 15.569
- Поени од реакции
- 18.603
Интересно два либерални медиуми со ист наратив, ајде да видиме дали нешто ќе се смени. Жалам пајвол се двата, ама насловите кажуваат се.
www.wsj.com
The incorrect hypothesis that natural immunity is unreliable has resulted in the loss of thousands of American lives, avoidable vaccine complications, and damaged the credibility of public health officials.
Opinion | Vaccine Mandates Can’t Stop Covid’s Spread
Coercion won’t work because those without symptoms can still pass on infection.
www.wsj.com
The incorrect hypothesis that natural immunity is unreliable has resulted in the loss of thousands of American lives, avoidable vaccine complications, and damaged the credibility of public health officials.
коцка
Curiouser and curiouser!
Чекам Тенџере или Гејатлеј после вакцина да се снимаат вака да глумат...
www.youtube.com
Anti-Vaxxer Faking Vaccine Side Effects on TikTok
Anti-vaxxer on TikTok is faking adverse effects to the vaccine, Fox News is requiring employees get the shot, FDA Full Authorization is on it's way and more ...
www.youtube.com
- Член од
- 30 август 2021
- Мислења
- 1.243
- Поени од реакции
- 2.628
@коцка види го, би бил епик фотонатпревар со рекордна посетеност и гласање.Чекам Тенџере или Гејатлеј после вакцина да се снимаат вака да глумат...
Anti-Vaxxer Faking Vaccine Side Effects on TikTok
Anti-vaxxer on TikTok is faking adverse effects to the vaccine, Fox News is requiring employees get the shot, FDA Full Authorization is on it's way and more ...
коцка
Curiouser and curiouser!
го гледам, не ме вознемирувај ќе ми предизвикаш неконтролирани тикови
- Член од
- 13 јули 2006
- Мислења
- 15.569
- Поени од реакции
- 18.603
FDA научниците одбија трета доза за 16 - 65 годишни. Дозволија само за 65 и постари. Ајде да видиме што ќе одлучат главните во FDA.
The panel earlier Friday afternoon voted to reject licensure of Pfizer's booster vaccine in people ages 16 and older, at a vote of 2-16.
During the deliberations, panel members suggested older, vulnerable populations may benefit from boosters, but noted insufficient data among younger groups and concerns over potential increased risk for heart inflammation, particularly among males ages 16-17.
A U.S. Food and Drug Administration (FDA) advisory panel on Friday endorsed emergency approval for the Pfizer-BioNTech COVID-19 vaccine booster shot at least six months following the second dose among people ages 65 and older and those at high risk of occupational exposure and severe COVID-19.
The vote was 18-0. The vote will now go before the FDA to issue a final decision.
www.foxnews.com
The panel earlier Friday afternoon voted to reject licensure of Pfizer's booster vaccine in people ages 16 and older, at a vote of 2-16.
During the deliberations, panel members suggested older, vulnerable populations may benefit from boosters, but noted insufficient data among younger groups and concerns over potential increased risk for heart inflammation, particularly among males ages 16-17.
A U.S. Food and Drug Administration (FDA) advisory panel on Friday endorsed emergency approval for the Pfizer-BioNTech COVID-19 vaccine booster shot at least six months following the second dose among people ages 65 and older and those at high risk of occupational exposure and severe COVID-19.
The vote was 18-0. The vote will now go before the FDA to issue a final decision.
FDA panel endorses Pfizer’s COVID-19 vaccine booster for people 65 and older, high-risk patients
A U.S. Food and Drug Administration (FDA) advisory panel on Friday endorsed emergency approval for the Pfizer-BioNTech COVID-19 vaccine booster shot at least six months following the second dose among people ages 65 and older and those at high risk of occupational exposure and severe COVID-19.
Последно уредено:
Сладоледџија
Ванила & Чоколадо
- Член од
- 8 декември 2009
- Мислења
- 14.458
- Поени од реакции
- 11.917
Daj nekoj link da ja procitame ovaa vest, vaka zvuci na pamet kako da zboris..
Убава и праведна желба, која би требало да се остварува после 20тина години.
Ти може си дигнал раце од системот, но тој нема дигнато од тебе, затоа му плаќаш секој месец 37% од твојот труд + 18%/5% на секој купен производ, + разни други давачки, акцизи и такси, + 10% ако извадиш дивиденда од своите пари (на кои веќе претходно си платил 10%) кои си ги заработил без помош од системот (напротив имаш блокади од него на секој чекор), а за возврат добиваш НИШТО, дури и те убиваат, дал со погрешна терапија, дал жив ќе изгориш.
И сега после сите овие работи што си ги напишал и по другите теми, како тоа ти и Рон пишувате дека мора да сме слепи послушници пред авторитет, ние сме глупите што бараме системот да се промени, или сите топтан ќе настрадаме, стварно не ве разбирам...
Се шалам, ве разбирам целосно, откако се запознав со работата на Стенли Милграм
Те молам не треси зелени, не ти личи на интелектот (како што и Бијонс ти напиша)
Живеам во заедница, ги почитувам сите, но мојот живот и здравје ми се најбитни. Мерките од системот кои ги браните го уништуваат здравјето на целата заедница, а ти никако да сфатиш разлика од систем и заедница. Те молам прочитај ја уште неколку пати разликата.
Твоите постапки и дозволување на корумпиран систем да прави што сака, дозволуваат цела популација да биде отпишана, па сеа ти види кој прави поголема штета, те бива со бројки.
Не знам дал си го слушал интервјуто со Бил Гејтс, каде кажува дека ц.ц. 700.000 луѓе ќе настрадаат (не дека сигурно ќе умрат) од вакцините. Да не навлегуваме како дошол до таа бројкаброј и дали е реална или ниска, тогаш и ти отпишуваш 700.000 луѓе, а мене ми проповедаш
@teneke ти текнува на времето, пред да преминеш кај фолијашите, со Анон колку го браневте Бил Геј
Не е глуп да се откаже да заработува 2000% во здравството на секој вложен 1$. Низ светот има фабрики со сите салтанати, кои можат да произведат стотици милиони вакцини, доколку патентот беше слободен. Во време на светска пандемија, тоа требаше прво нешто да се направи, доколку намерите беа чесни, арно ама ....
Xibalba
Господин Господин
Редовна саботна доза ќотек во Мелбурн, во Сиднеј да дојдеше Папата лично немаше да има волку полиција, ги растурија протестатните уште пред да се соберат:
www.news.com.au
Може @kano има повеќе информации од прва рака како поминал на протестите
Violence erupts at anti-lockdown protests
Six police officers were taken to hospital with serious injuries, including broken bones, after they violently clashed with hundreds of anti-lockdown protesters in Melbourne.
www.news.com.au
Може @kano има повеќе информации од прва рака како поминал на протестите
- Член од
- 13 јули 2006
- Мислења
- 15.569
- Поени од реакции
- 18.603
Значи во Израел се исплашиле затоа што 60% од сите тешки случаи му биле во вакцинирани и 45% од смртните. Затоа во паника почнаа да даваат трета доза.
WASHINGTON — A key advisory panel to the Food and Drug Administration overwhelmingly rejected recommending Pfizer booster shots for most recipients of the company’s coronavirus vaccine, instead endorsing them only for people who are 65 or older or at high risk of severe Covid-19, and received their second dose at least six months ago.
Committee members appeared dismissive of the argument that the general population needed booster shots, saying the data from Pfizer and elsewhere still seemed to show two shots protected against severe disease or hospitalization and did not prove a third shot would stem the spread of infection. Some also criticized a lack of data that an additional injection would be safe for younger people.
The committee of largely outside experts voted 16 to 2 against a Pfizer booster for people 16 and older after a tense daylong public discussion that put divisions in the agency and the administration on public display. Officials from the Centers for Disease Control and Prevention and the National Institutes of Health joined infectious disease experts and doctors in voting against additional shots for such a broad swath of the population.
In a statement about Friday’s vote, Kathrin U. Jansen, senior vice president and head of vaccine research and development at Pfizer, said, “We thank the committee for their thoughtful review of the data and will work with the F.D.A. following today’s meeting to address the committee’s questions, as we continue to believe in the benefits of a booster dose for a broader population.”
The meeting “put the F.D.A. back in the driver’s seat,” said Dr. Luciana Borio, a former acting chief scientist at the agency. The expert panel, she said, “was allowed to maintain its scientific independence. It understood there were significant limitations with the data presented and that the F.D.A. needs to review the data carefully before making a decision.”
The panel listened to hours of contradictory presentations by officials from Pfizer, the C.D.C., the Israeli government and independent experts about the waning effectiveness of Pfizer and other vaccines over time.
Dr. Sara Oliver of the C.D.C. presented data showing that vaccines continue to strongly protect against severe forms of Covid-19 in the United States, even in people 75 and older.
Jonathan Sterne, a professor of medical statistics and epidemiology in Britain, said he had analyzed 76 different studies on the vaccines’ real-world effectiveness and found that multiple factors could skew the results, including how many unvaccinated people in a study had natural immunity from prior infection. He also warned against drawing conclusions from short-term results from booster shots; data from Israel, for example, only included a follow-up period of several weeks for older adults.
Israeli experts made a different argument, telling the committee that they believed third Pfizer shots helped dampen a fourth wave of transmission as the Delta variant swept the nation this summer. The Israeli government, which has relied almost entirely on the Pfizer vaccine, began offering booster shots in late July, starting with the older adults.
Dr. Sharon Alroy-Preis, Israel’s head of public health services, said the summer’s rise in the number of hospitalized patients who had been fully vaccinated with Pfizer’s vaccine was “scary.” She said 60 percent of severely or critically ill patients and 45 percent of those who died during what she called the fourth surge had received two injections of Pfizer’s vaccine.
After offering boosters to the general population, she said, Israel was now averaging about half as many severe or critically ill patients as anticipated. She said boosters not only helped curb the spread of infection, but also “actually saved lives.”
Dr. William C. Gruber, a senior Pfizer vice president in charge of vaccine development, suggested that if the United States does not follow Israel’s lead, it could face more than five million more infections a year among people who received their second dose 10 months earlier, compared to those who got the second shot five months earlier.
“Israel could portend the U.S. Covid-19 future, and soon,” he said.
He said Pfizer’s data showed that a third shot elicited a robust antibody immune response that equaled or greatly exceeded the response after the second dose. Data also show, he argued, that breakthrough infections among vaccinated Americans are linked more to the ebbing power of the vaccine over time than to the Delta variant.
But committee members and some government officials appeared deeply skeptical. Dr. Philip Krause, one of the F.D.A. vaccine experts who wrote the medical journal review, criticized Pfizer’s presentation of data that had not been peer-reviewed or evaluated by the F.D.A., arguing that problems in the modeling in a study underpinning the company’s case understated the vaccine’s efficacy.
Dr. Oliver, the C.D.C. official, questioned attempts to draw a parallel between the United States and Israel, noting that Israel has only nine million residents and is less diverse than the United States. Notably, she also said that Israel defines a severe case of Covid-19 more broadly than the United States does, which might help explain why Israel reports more serious breakthrough infections among its vaccinated residents.
Another C.D.C. official, Dr. Amanda Cohn, asked Israeli officials why the spread of the virus there had recently intensified, despite a broad rollout of boosters. Dr. Alroy-Preis said that the Jewish holidays, along with the start of the school year, had contributed to what she suggested would be a temporary surge in cases.
Committee members also said they were concerned about a paucity of safety data in younger recipients of a booster dose, since studies have shown a higher risk of myocarditis, an inflammation of the heart muscle, in young men who received Pfizer-BioNTech’s vaccine. Several asked whether it would be better to wait for a booster vaccine devised specifically to fend off the Delta variant of the virus.
One study apparently came too late for the discussion, underscoring the rapid flurry of changing data on vaccine potency. Released by the C.D.C. hours before the committee’s vote, it found that the Pfizer vaccine’s level of protection against coronavirus hospitalizations dropped significantly four months after the second shot.
The study found that two weeks to four months after recipients got their second dose, the Pfizer vaccine was 91 percent effective in preventing hospitalization. After 120 days, though, its effectiveness fell to 77 percent. Moderna’s vaccine showed no comparable decrease in protection over the same time frame. The vaccinated patients in the study tended to be older; the Pfizer cohort had a median age of 68.
The New York Times: F.D.A. Panel Recommends Pfizer Boosters for Those Over 65 or at Risk.
www.nytimes.com
WASHINGTON — A key advisory panel to the Food and Drug Administration overwhelmingly rejected recommending Pfizer booster shots for most recipients of the company’s coronavirus vaccine, instead endorsing them only for people who are 65 or older or at high risk of severe Covid-19, and received their second dose at least six months ago.
Committee members appeared dismissive of the argument that the general population needed booster shots, saying the data from Pfizer and elsewhere still seemed to show two shots protected against severe disease or hospitalization and did not prove a third shot would stem the spread of infection. Some also criticized a lack of data that an additional injection would be safe for younger people.
The committee of largely outside experts voted 16 to 2 against a Pfizer booster for people 16 and older after a tense daylong public discussion that put divisions in the agency and the administration on public display. Officials from the Centers for Disease Control and Prevention and the National Institutes of Health joined infectious disease experts and doctors in voting against additional shots for such a broad swath of the population.
In a statement about Friday’s vote, Kathrin U. Jansen, senior vice president and head of vaccine research and development at Pfizer, said, “We thank the committee for their thoughtful review of the data and will work with the F.D.A. following today’s meeting to address the committee’s questions, as we continue to believe in the benefits of a booster dose for a broader population.”
The meeting “put the F.D.A. back in the driver’s seat,” said Dr. Luciana Borio, a former acting chief scientist at the agency. The expert panel, she said, “was allowed to maintain its scientific independence. It understood there were significant limitations with the data presented and that the F.D.A. needs to review the data carefully before making a decision.”
The panel listened to hours of contradictory presentations by officials from Pfizer, the C.D.C., the Israeli government and independent experts about the waning effectiveness of Pfizer and other vaccines over time.
Dr. Sara Oliver of the C.D.C. presented data showing that vaccines continue to strongly protect against severe forms of Covid-19 in the United States, even in people 75 and older.
Jonathan Sterne, a professor of medical statistics and epidemiology in Britain, said he had analyzed 76 different studies on the vaccines’ real-world effectiveness and found that multiple factors could skew the results, including how many unvaccinated people in a study had natural immunity from prior infection. He also warned against drawing conclusions from short-term results from booster shots; data from Israel, for example, only included a follow-up period of several weeks for older adults.
Israeli experts made a different argument, telling the committee that they believed third Pfizer shots helped dampen a fourth wave of transmission as the Delta variant swept the nation this summer. The Israeli government, which has relied almost entirely on the Pfizer vaccine, began offering booster shots in late July, starting with the older adults.
Dr. Sharon Alroy-Preis, Israel’s head of public health services, said the summer’s rise in the number of hospitalized patients who had been fully vaccinated with Pfizer’s vaccine was “scary.” She said 60 percent of severely or critically ill patients and 45 percent of those who died during what she called the fourth surge had received two injections of Pfizer’s vaccine.
After offering boosters to the general population, she said, Israel was now averaging about half as many severe or critically ill patients as anticipated. She said boosters not only helped curb the spread of infection, but also “actually saved lives.”
Dr. William C. Gruber, a senior Pfizer vice president in charge of vaccine development, suggested that if the United States does not follow Israel’s lead, it could face more than five million more infections a year among people who received their second dose 10 months earlier, compared to those who got the second shot five months earlier.
“Israel could portend the U.S. Covid-19 future, and soon,” he said.
He said Pfizer’s data showed that a third shot elicited a robust antibody immune response that equaled or greatly exceeded the response after the second dose. Data also show, he argued, that breakthrough infections among vaccinated Americans are linked more to the ebbing power of the vaccine over time than to the Delta variant.
But committee members and some government officials appeared deeply skeptical. Dr. Philip Krause, one of the F.D.A. vaccine experts who wrote the medical journal review, criticized Pfizer’s presentation of data that had not been peer-reviewed or evaluated by the F.D.A., arguing that problems in the modeling in a study underpinning the company’s case understated the vaccine’s efficacy.
Dr. Oliver, the C.D.C. official, questioned attempts to draw a parallel between the United States and Israel, noting that Israel has only nine million residents and is less diverse than the United States. Notably, she also said that Israel defines a severe case of Covid-19 more broadly than the United States does, which might help explain why Israel reports more serious breakthrough infections among its vaccinated residents.
Another C.D.C. official, Dr. Amanda Cohn, asked Israeli officials why the spread of the virus there had recently intensified, despite a broad rollout of boosters. Dr. Alroy-Preis said that the Jewish holidays, along with the start of the school year, had contributed to what she suggested would be a temporary surge in cases.
Committee members also said they were concerned about a paucity of safety data in younger recipients of a booster dose, since studies have shown a higher risk of myocarditis, an inflammation of the heart muscle, in young men who received Pfizer-BioNTech’s vaccine. Several asked whether it would be better to wait for a booster vaccine devised specifically to fend off the Delta variant of the virus.
One study apparently came too late for the discussion, underscoring the rapid flurry of changing data on vaccine potency. Released by the C.D.C. hours before the committee’s vote, it found that the Pfizer vaccine’s level of protection against coronavirus hospitalizations dropped significantly four months after the second shot.
The study found that two weeks to four months after recipients got their second dose, the Pfizer vaccine was 91 percent effective in preventing hospitalization. After 120 days, though, its effectiveness fell to 77 percent. Moderna’s vaccine showed no comparable decrease in protection over the same time frame. The vaccinated patients in the study tended to be older; the Pfizer cohort had a median age of 68.
The New York Times: F.D.A. Panel Recommends Pfizer Boosters for Those Over 65 or at Risk.
F.D.A. Advisory Panel Recommends Pfizer Boosters for Older People and Others at High Risk (Published 2021)
The committee said there was insufficient evidence to recommend third shots for all adult recipients of the vaccine, as Pfizer had requested.
Последно уредено:
Lester Freamon
A man of focus, commitment, sheer will...
- Член од
- 14 јануари 2015
- Мислења
- 16.241
- Поени од реакции
- 36.549
Ако ти имаш начин како да се избегне плаќање кон системот (без да се оди во затвор), ќе те земам да ми го водиш сметководството
Кој ги гласа тие што го водат системот? Од каде доаѓаат тие, ни ги носи некој од Марс, или исто од нас?И сега после сите овие работи што си ги напишал и по другите теми, како тоа ти и Рон пишувате дека мора да сме слепи послушници пред авторитет, ние сме глупите што бараме системот да се промени, или сите топтан ќе настрадаме, стварно не ве разбирам...
Се шалам, ве разбирам целосно, откако се запознав со работата на Стенли Милграм
Те молам не треси зелени, не ти личи на интелектот (како што и Бијонс ти напиша)
Живеам во заедница, ги почитувам сите, но мојот живот и здравје ми се најбитни. Мерките од системот кои ги браните го уништуваат здравјето на целата заедница, а ти никако да сфатиш разлика од систем и заедница. Те молам прочитај ја уште неколку пати разликата.
Твоите постапки и дозволување на корумпиран систем да прави што сака, дозволуваат цела популација да биде отпишана, па сеа ти види кој прави поголема штета, те бива со бројки.
Не знам дал си го слушал интервјуто со Бил Гејтс, каде кажува дека ц.ц. 700.000 луѓе ќе настрадаат (не дека сигурно ќе умрат) од вакцините. Да не навлегуваме како дошол до таа бројкаброј и дали е реална или ниска, тогаш и ти отпишуваш 700.000 луѓе, а мене ми проповедаш
@teneke ти текнува на времето, пред да преминеш кај фолијашите, со Анон колку го браневте Бил Геј
Не е глуп да се откаже да заработува 2000% во здравството на секој вложен 1$. Низ светот има фабрики со сите салтанати, кои можат да произведат стотици милиони вакцини, доколку патентот беше слободен. Во време на светска пандемија, тоа требаше прво нешто да се направи, доколку намерите беа чесни, арно ама ....
Инаку еве ти ги статистиките и дали се умира од вирусот или не.
Вкупен број на смртни случаеви (не само корона), ај примети во кои недели е највисок, и дали има таков во моментов иако имаат над 30к заболени дневно (дека не помагаат вакцините
).
А еве ти и само за ковид, додека имаа мал број на вакцинирани (зимата и пролет) пепел, последните 5-6 месеци штама.
Првиот график ти го ставив да видиш дека и вкупниот број на смртни случаи бил зголемен во тие месеци, а не како што тврдите тука дека ги пишувале умрени од ковид од било која болест.